Submit a Story!
Jane Hamsher: Anna Eshoo's PhRMA Boondoggle:  The Devil Is In Her Details
Jane Hamsher: Anna Eshoo's PhRMA Boondoggle: The Devil Is In Her Details
As a three time breast cancer survivor, I have a strong personal stake in health care reform. So when students from the American Medical Students Association wrote us at PublicOptionPlease.com and told me about their campaign to keep biologic "drugs of the future" available and affordable, I ...
Waxman to Eshoo: You’ve Got an “Evergreening Problem”
Waxman to Eshoo: You’ve Got an “Evergreening Problem”
fdlaction.firedoglake.com — In her response to my article on her biologics bill, Anna Eshoo vehemently claims it doesn’t allow... “evergreening,” which would allow slight tweaks in drug formulas to grant drug companies endless monopolies and keep these ... (more) Waxman to Eshoo: You’ve Got an “Evergreening Problem”
Eshoo, AMSA, and Me: A Visit to the Senate to Stop Pro-PhRMA Bill
Eshoo, AMSA, and Me: A Visit to the Senate to Stop Pro-PhRMA Bill
fdlaction.firedoglake.com — I had the best time last week for Halloween. I went to the Senate on behalf of... POP with the medical students from AMSA who first alerted me to the problems in Anna Eshoo’s (D-PhRMA) bill, which would grant monopolies on expensive, ... (more) Eshoo, AMSA, and Me: A Visit to the Senate to Stop ...
The Devil in Anna Eshoo’s Details
The Devil in Anna Eshoo’s Details
fdlaction.firedoglake.com — The Devil in Anna Eshoo’s Details (more) The Devil in Anna Eshoo’s Details
Comments
Blog Reactions

Eshoo, AMSA, and Me: A Visit to the Senate to Stop Pro-PhRMA Bill
Firedoglake — ... Eshoo’s bill will grant a 12 year monopoly to drug companies on biologic “drugs of the future,” whereas conventional drugs only have 5 years. And because of an “evergreening” provision (which Eshoo denies is included in her bill, but Henry Waxman insists is very much there when he condemned it) that monopoly can be extended by slight tweeks in the drugs. ...

Marcy Winograd: Jane Harman Profits from Anti-Generics Amendment She Helped Eshoo Pass
Firedoglake — ... Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn’t have done it without the help of her good friend Jane Harman. A new letter from the Marcy Winograd campaign says: ...

FDL Action Health Care Update: Friday (11/6/09)
Blue Commonwealth - Front Page — ... that "Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn't have done it without the help of her good friend Jane Harman." Hamsher urges everyone to ...

The Algebra of Need: Cancer, Biologics, PhRMA
Firedoglake — ... Senator Sherrod Brown and Congressman Henry Waxman introduced legislation that would give the manufacturers of biologics a five-year window to reap the profits of exclusivity – and then open the door to generic competitors.  But they lost out to language from Senator Hagan and Rep. Eshoo, which would give the Genentech/Roches of this world twelve years of exclusivity – and then allows that exclusivity to be extended indefinitely, simply by changing to recommended dosage or administration of the drug. ...

Related Content
Jane Hamsher: House Health Care Bill: A Death Sentence For My Fellow Breast Cancer Survivors
huffingtonpost.com 10/30/2009 — There was much celebration on Capitol Hill today with the announcement of the new House health care bill . For myself, as a three time breast cancer survivor, there was tremendous sadness and disappointment in the Speaker. Nancy Pelosi made a ...
Setting the record straight on our health care legislation (Rep. Anna Eshoo)
thehill.com 11/2/2009 — Like millions of Americans, I was thrilled by today's unveiling by Speaker Pelosi of the House health care reform bill, the Affordable Health Care for Read more...
Welcome to Relative Backwardness
mydd.com 24 days ago — After the release of the October unemployment data that reported a steeper than expected rise to 10.2%, I decided to revisit an old college text, The Zero Sum Society: Distribution and the Possibility for Change , the seminal work of MIT economist ...
Marcy Winograd: Jane Harman Profits from Anti-Generics Amendment She Helped Eshoo Pass
fdlaction.firedoglake.com 29 days ago — Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs , but she couldn’t have done it without the help of her good friend Jane Harman. A new letter from the Marcy Winograd campaign ...
Henry Waxman says Anna Eshoo Has An "Evergreening Problem" (video)
youtube.com 11/2/2009 — Henry Waxman on July 31, 2009 at the Energy and Commerce markup, on Anna Eshoos biosimilar amendment to H.R.3200: "I know that members of this commi...
Will PhRMA’s Fax Machines in the Senate Continue Eshoo’s Work?
fdlaction.firedoglake.com 19 days ago — Ask Sherrod Brown to save us from PhRMA and the Eshoo/Hagan/ lobbyist-written biologics legislation HERE. Well, we now know that 42 bipartisan members of the House were willing to act act as PhRMA’s fax machines. I guess it shouldn’t ...
Let's Make a Deal
prospect.org 10/29/2009 — A look at the lobbying groups that shelled out the big bucks to influence health-care reform.
Help Sherrod Brown Get Bipartisan Support for Health Care Reform
fdlaction.firedoglake.com 11/3/2009 — In the Senate, Kay Hagan sponsored an almost identical piece of legislation to Rep. Eshoo’s on biologic drugs , which would keep important lifesaving treatments for breast cancer and other diseases which can cost $50,000 or $300,000 a ...
Join Me and Medical Students Today to Treat, Not Trick for Generic Drugs!
fdlaction.firedoglake.com 10/31/2009 — Meet at Union Station at 2:30pm; Walk to Russell Office Bldg. at 3pm I’m going to be at the Russell Senate office building today with Laura Musselwhite, the wonderful medical student from Duke University who wrote this incredible op-ed in ...
Public Option Please
publicoptionplease.com 11/2/2009 — In the health care bill in Congress, there’s a dangerous provision about “biologics” drugs that will make it virtually impossible for patients of breast cancer, rheumatoid arthritis, and Crohn’s disease to have access to affordable medication. ...